Skip to main content

Table 2 Frequency of liver-related events in HIV/HCV-coinfected patients according to mitochondrial DNA haplogroup

From: European mitochondrial haplogroups predict liver-related outcomes in patients coinfected with HIV and HCV: a retrospective study

mtDNA haplogroup

With haplogroup

All patients

Excluding patients with SVR

H

No

15/134 (11.2%)*

12/82 (14.6%)*

Yes

3/109 (2.8%)

3/71 (4.2%)

V

No

17/227 (7.5%)

14/144 (9.7%)

Yes

1/16 (6.3%)

1/9 (11.1%)

pre V

No

17/238 (7.1%)

14/149 (9.4%)

Yes

1/5 (20%)

1/4 (25%)

HV

No

13/113 (11.5%)*

10/69 (14.5%)

Yes

5/130 (3.8%)

5/84 (6%)

U

No

10/179 (5.6%)

9/115 (7.8%)

Yes

8/64 (12.5%)

6/38 (15.8%)

J

No

18/228 (7.9%)

15/145 (10.3%)

Yes

0/15 (0%)

0/8 (0%)

T

No

13/218 (6%)*

11/137 (8%)*

Yes

5/25 (20%)

4/16 (25%)

JT

No

13/203 (6.4%)

11/129 (8.5%)

Yes

5/40 (12.5%)

4/24 (16.7%)

I

No

18/238 (7.6%)

15/149 (10.1%)

Yes

0/5 (0%)

0/4 (0%)

X

No

18/240 (7.5%)

15/151 (9.9%)

Yes

0/3 (0%)

0/2 (0%)

W

No

18/242 (7.4%)

15/152 (9.9%)

Yes

0/1 (0%)

0/1 (0%)

IXW

No

18/234 (7.7%)

15/146 (10.3%)

Yes

0/9 (0%)

0/7 (0%)

 

Total

18/243 (7.4%)

15/153 (9.8%)

  1. LRE liver-related event, SVR sustained virological response
  2. * p < 0.05